Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 23, Issue SUPPL. 1, 2010, Pages

  Goodman, Nicola ^a   Morgan, Mike ^a   Nikander, Kurt ^b   Hinch, Sarah ^c   Coughlin, Steven ^c  

^a GLENFIELD HOSPITAL   (United Kingdom)

^b PHILIPS HEALTHCARE   (United States)

^c Respiratory Drug Delivery UK Ltd   (United Kingdom)

Author keywords

Adaptive aerosol delivery; Ease of use; I neb AAD system; Mesh nebulizer; Nebulizer; Patient satisfaction; Quality of life

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY QUESTIONNAIRE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG DELIVERY SYSTEM; DYSPNEA; EMOTION; EVALUATION; FATIGUE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE STIFFNESS; NAUSEA; NEBULIZER; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SORE TONGUE; STATISTICAL SIGNIFICANCE; STIFF NECK; TONGUE DISEASE; TREATMENT OUTCOME; VALIDATION PROCESS; WILCOXON SIGNED RANKS TEST;

ADMINISTRATION, INHALATION; AEROSOLS; AGED; AGED, 80 AND OVER; BRONCHODILATOR AGENTS; DRUG DELIVERY SYSTEMS; DYSPNEA; FATIGUE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PATIENT SATISFACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC;

EID: 77950601402     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2009.0767     Document Type: Article

References (19)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2007. Available at; http:==www.goldcopd.com. Accessed September 30, 2008.
2. Jones PW, Willits LR, Burge PS, and Calverley PM: Inhaled Steroids in Obstructive Lung Disease in Europe study investigators. Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. Eur Respir J. 2003;21:68-73. (Pubitemid 36150303)
3. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, Smaldone GC, and Guyatt G: Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians=American College of Asthma, Allergy, and Immunology. Chest. 2005;127:335-371. (Pubitemid 41724594)
4. Anderson P: Patient preference for and satisfaction with inhaler devices. Eur Respir Rev. 2005;96:109-116. (Pubitemid 43028768)
5. O'Callaghan C, and Barry PW: The science of nebulized drug delivery. Thorax 1997;52(Suppl 2):S31-S44.
6. Dhand R: Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care. 2002;47: 1406-1416.
7. Nikander K: Drug delivery systems. J Aerosol Med. 1994;7(Suppl 1):S19-S24. (Pubitemid 24295379)
8. Nikander K, Turpeinen M, and Wollmer P: The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension. J Aerosol Med. 1999;12:47-53. (Pubitemid 29266597)
9. Steckel H, and Eskandar F: Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers. Eur J Pharm Sci. 2003;19:443-455. (Pubitemid 36952406)
10. Nikander K, and Denyer J: Adaptive Aerosol Delivery (AAD) Technology. In: Rathbone MJ (ed). Modified Release Drug Delivery Technology, 2nd ed. Informa Healthcare USA, Inc., New York; pp. 603-612, 2008.
11. Waldrep JC, and Dhand R: Advanced nebulizer designs employing vibrating mesh=aperture plate technologies for aerosol generation. Curr Drug Deliv. 2008;5:114-119. (Pubitemid 351536317)
12. Bosley CM, Corden ZM, Rees PJ, and Cochrane GM: Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J. 1996;9:2346-2350. (Pubitemid 26366665)
13. Corden ZM, Bosley CM, Rees PJ, and Cochrane GM: Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. Chest. 1997;112;1278-1282.
14. NICE guidelines: Diagnosing COPD. Thorax. 2004;59;i27- i38.
15. Guyatt GH, Townsend M, Berman LB, and Pugsley SO: Quality of life in patients with chronic airflow limitation. Br J Dis Chest. 1987;81:45-54. (Pubitemid 17013494)
16. Schünemann HJ, Puhan M, Goldstein R, Jaeschke R, and Guyatt GH: Measurement properties and interpretability of the chronic respiratory disease questionnaire (CRQ). COPD. 2005;2:81-89. (Pubitemid 40778678)
17. Barta SK, Crawford A, and Roberts CM: Survey of patients' views of domiciliary nebulizer treatment for chronic lung disease. Respir Med. 2002;96:375-381. (Pubitemid 36443152)
18. Chapman KR, Walker L, Cluley S, and Fabbri L: Improving patient compliance with asthma therapy. Respir Med. 2000;94:2-9. (Pubitemid 30113844)
19. Hardy JG, Newman SP, and Knoch M: Lung deposition from four nebulizers. Respir Med. 1993;87:461-465.. (Pubitemid 23266355)